Todd Watanabe

See Remarks

Todd Watanabe (See Remarks) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.5M of ARQT (48,945 sh × $30.36, as filed), executed Nov 24 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.2M

shares × price, as filed

Last traded

Aug 3

Filed Aug 5

Median ADV $51.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

ARQT

Arcutis Biotherapeutics, Inc. ARQT · 0 buys · 9 sells 9 filings

Recent filings

ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $114K
4,375 sh × $26.12
Exec Aug 3
Filed Aug 5 · 9:42 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $913K
36,281 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $506K
19,833 sh × $25.50
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $1.5M
48,945 sh × $30.36
Exec Nov 24 2025
Filed Nov 24 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $284K
11,478 sh × $24.71
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $1.0M
40,000 sh × $25.03
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $885K
45,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $169K
9,625 sh × $17.54
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET More filings →